Activating mutations in ERBB2 and their impact on diagnostics and treatment
Despite the ongoing ‘war on cancer’, cancer remains one of the major causes of human morbidity and mortality. A new paradigm of targeted therapies holds the most promise for the future, making identification of tumor-specific therapeutic targets of prime importance. ERBB2, best known for its role in...
| Autores principales: | , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2013-04-01
|
| Colección: | Frontiers in Oncology |
| Materias: | |
| Acceso en línea: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00086/full |